Evidence for allosteric variants of wild-type p53, a tumour suppressor protein
1990

Variants of the p53 Tumor Suppressor Protein

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): A. Cook, J. Milner

Primary Institution: University of Cambridge

Hypothesis

Wild type p53 can exist in two specific conformations that may represent allosteric variants with different functions in cell growth control.

Conclusion

The study demonstrates that wild type p53 can adopt two conformations, which may have distinct roles in regulating cell proliferation.

Supporting Evidence

  • Wild type p53 can be expressed in two forms, p53-246+ and p53-246?.
  • Loss of wild type p53 is associated with cancer progression.
  • Different reticulocyte lysates produced different conformations of p53.
  • Monoclonal antibodies were used to distinguish between p53 variants.

Takeaway

This study found that a protein called p53, which helps prevent cancer, can change its shape in two ways, and each shape does different things in the body.

Methodology

The study involved translating p53 mRNA in vitro using different reticulocyte lysates and analyzing the resulting protein variants with monoclonal antibodies.

Limitations

The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication